30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Genmab A/S (GMAB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 0 | $0 | -100% | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,614,510 | $497,165,998 | 0.19% | |
| 2. | 4,409,575 | $140,400,861 | 0% | |
| 3. | 4,057,922 | $129,650,575 | 0.02% | |
| 4. | 3,289,895 | $97,568,587 | 0.54% | |
| 5. | 2,369,331 | $75,439,498 | 0.01% |
News See All
Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript
Genmab A/S misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.35.
12 High Growth International Stocks to Buy
In this article, we discuss the 12 high growth international stocks to buy.
Genmab A/S (NASDAQ:GMAB) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to Genmab's Third Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Genmab A/S (NASDAQ:GMAB) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to Genmab's Second Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Genmab A/S (NASDAQ:GMAB) Q1 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Genmab's First Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
15 Most Profitable Growth Stocks Now
Growth stocks refer to listed companies that are growing their profits, revenue, or cash flow at a rate that exceeds their competitors and beats the overall market.
5 High Growth International Stocks to Buy
SolarEdge Technologies, Inc. (NASDAQ:SEDG) was incorporated in 2006 and is headquartered in Herzliya, Israel.
Genmab A/S (NASDAQ:GMAB) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to the Genmab Full-year 2022 Conference Call. As a reminder, this conference call is being recorded.